XML 42 R31.htm IDEA: XBRL DOCUMENT v3.25.1
SEGMENT REPORTING (Tables)
3 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
SCHEDULE OF INFORMATION RELATED TO OPERATIONS OF REPORTABLE OPERATING SEGMENTS

The following table presents information about the Company’s reportable segments for the year ended March 31, 2025 and 2024:

 

   2025   2024 
   Three months ended 
   March 31 
   2025   2024 
         
Revenue from pathogen prevention and prolong shelf life   66    44 
Cost related to pathogen prevention and prolong shelf life   (270)   (235)
Operating loss from Pathogen prevention and prolong shelf life   (204)   (191)
           
Revenue from renewable energy projects   -    - 
Cost related to renewable energy projects   (71)   - 
Operating loss from Renewable energy projects   (71)   - 
           
Research and development expenses   -    (103)
Professional services   (238)   (302)
Share base compensation   (41)   (140)
Depreciation   (3)   (5)

Interest of loans

   

(77

)   

-

 
Other general and administrative expenses   (62)   (158)
Total Operating loss   (421)   (708)
           
Financing (expenses) income, net   (736)   5 
Other loss   -    (12)
Changes in fair value of investments measured under the fair value option   175    84 
Net loss   (1,257)   (822)